The CAPN3 gene muscular dystrophy limb-girdle type 2A genetic test is a specialized diagnostic procedure designed to identify mutations in the CAPN3 gene, which are responsible for causing limb-girdle muscular dystrophy type 2A (LGMD2A). LGMD2A is a form of muscular dystrophy that primarily affects the muscles around the hips and shoulders, leading to progressive muscle weakness and atrophy. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease.
The test is conducted by DNA Labs UAE, a leading facility in genetic diagnostics and research. Utilizing advanced genetic sequencing technologies, the laboratory examines the CAPN3 gene for any mutations that are known to cause LGMD2A. This precise genetic testing is crucial for accurate diagnosis, enabling targeted management and treatment strategies for affected individuals. Additionally, it can provide valuable information for family planning and genetic counseling for families with a history of this condition.
The cost of the CAPN3 gene muscular dystrophy limb-girdle type 2A genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers critical insights for the diagnosis and management of LGMD2A, potentially improving the quality of life for those affected by this challenging condition.
The PLEC Gene Muscular Dystrophy Limb-Girdle Type 2Q Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the PLEC gene, which are associated with Limb-Girdle Muscular Dystrophy Type 2Q (LGMD2Q). This condition is a part of a group of genetic muscle diseases known for weakening and wasting away of the limb muscles, particularly around the hips and shoulders (limb-girdle area). The test is crucial for individuals showing symptoms of the disease or those with a family history, as it can confirm the diagnosis and help in managing the condition effectively.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA to look for specific mutations in the PLEC gene that are known to cause LGMD2Q. The process is meticulous and requires a sample of the patient's blood or saliva.
The cost of the PLEC Gene Muscular Dystrophy Limb-Girdle Type 2Q Genetic Test at DNA Labs UAE is 4400 AED. Although the price might seem high, it reflects the sophisticated technology and expertise required to accurately identify mutations in the PLEC gene. For patients and families affected by LGMD2Q, this test offers valuable insights into the condition, enabling informed decisions about treatment and management strategies.
The PABPN1 Gene Muscular Dystrophy Oculopharyngeal Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PABPN1 gene, which are linked to Oculopharyngeal Muscular Dystrophy (OPMD). OPMD is a rare genetic disorder characterized by progressive muscle weakness affecting the eyes (ocular) and throat (pharyngeal), typically manifesting in adulthood. The test plays a crucial role in the early detection and management of the condition, allowing for tailored treatment plans and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze the genetic material for mutations associated with this condition. By opting for this test at DNA Labs UAE, patients gain access to critical information that can significantly impact their quality of life and that of future generations.
The RXYLT1 gene muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A10 genetic test is a specialized diagnostic assessment offered by DNA Labs UAE. This test is designed to identify mutations in the RXYLT1 gene, which are associated with a rare form of muscular dystrophy known as dystroglycanopathy congenital with brain and eye anomalies type A10. This condition is characterized by muscle weakness and wasting, along with severe developmental issues affecting the brain and eyes.
The genetic test involves analyzing the patient's DNA to detect any abnormalities or mutations in the RXYLT1 gene that may lead to the disease. Early diagnosis through this genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling to affected families.
DNA Labs UAE, a leading provider of genetic testing services in the region, offers this comprehensive test at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring high-quality, reliable results. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and future.
The B4GAT1 gene plays a critical role in the development and function of muscles, the brain, and the eyes. Mutations in this gene can lead to Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A13 (MDDGA13), a rare genetic disorder characterized by muscle weakness, developmental delays, and structural abnormalities in the brain and eyes. To diagnose this condition, genetic testing is essential.
DNA Labs UAE offers a specialized genetic test for MDDGA13, focusing on identifying mutations in the B4GAT1 gene. This test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options. The test is available for a cost of 4400 AED. Conducting this test can provide vital information for affected individuals and their families, enabling them to make informed decisions about their healthcare and manage the condition more effectively.
The POMT2 gene plays a crucial role in the development and function of muscles and the brain. Mutations in this gene can lead to a form of muscular dystrophy-dystroglycanopathy, specifically categorized as Congenital with Brain and Eye Anomalies Type A2 (MDDGA2). This condition is characterized by muscle weakness, developmental delays, and abnormalities in the brain and eyes from birth. Genetic testing for mutations in the POMT2 gene is essential for diagnosing this disorder, enabling early intervention and management of symptoms.
DNA Labs UAE offers a comprehensive genetic test to identify mutations in the POMT2 gene, providing crucial information for affected families. The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory. Results from this test can help in confirming the diagnosis, understanding the severity of the condition, and informing treatment options. It also aids in genetic counseling, offering families insights into the risk of the condition recurring in future pregnancies.
The POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A3 (MDDGA3) genetic test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the POMGNT1 gene. This gene plays a critical role in the development and functioning of muscles, brain, and eyes. Mutations in the POMGNT1 gene are associated with a rare form of muscular dystrophy known as MDDGA3, characterized by congenital muscular dystrophy coupled with brain and eye anomalies.
This comprehensive test is crucial for early diagnosis and management of MDDGA3, enabling healthcare providers to tailor specific treatment plans and interventions that can significantly improve the quality of life for affected individuals. The test cost is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic mutations associated with this condition. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate and actionable health information, this test represents a critical step forward for patients and families facing the challenges of MDDGA3.
The POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the POMGNT2 gene. This gene plays a crucial role in the proper development and functioning of muscles, the brain, and eyes. Mutations in POMGNT2 can lead to a rare form of muscular dystrophy-dystroglycanopathy, which is characterized by congenital muscular dystrophy coupled with brain and eye anomalies, classified as Type A8.
This genetic test is essential for the early detection and diagnosis of this condition, enabling healthcare providers to develop a tailored management and treatment plan for affected individuals. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for any genetic abnormalities associated with the condition.
The cost of the POMGNT2 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A8 genetic test at DNA Labs UAE is 4400 AED. Given the complexity and specificity of this test, it represents a crucial investment in the health and well-being of individuals at risk of or suspected to have this rare disorder. Early diagnosis through genetic testing can significantly impact the quality of life, allowing for timely interventions and support for those affected and their families.
The POMT1 gene plays a critical role in the development and maintenance of muscle and brain tissue. Mutations in the POMT1 gene can lead to a rare form of muscular dystrophy-dystroglycanopathy, specifically categorized as congenital with mental retardation type B1. This condition is characterized by severe muscle weakness from birth, brain abnormalities, and, in many cases, intellectual disabilities.
To diagnose this condition, a genetic test is available at DNA Labs UAE, which can identify mutations in the POMT1 gene. The test is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions regarding the management and care of affected individuals. The cost of the test is 4400 AED, and it involves analyzing the patient's DNA sample for the presence of mutations in the POMT1 gene that are known to cause the disease. This genetic test is a valuable tool for families seeking answers about this rare condition, offering insights into potential treatments and interventions that can improve the quality of life for those affected.
The POMT2 gene muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) genetic test is a specialized diagnostic assessment available at DNA Labs UAE. This test is designed to identify mutations in the POMT2 gene, which are known to cause a rare form of muscular dystrophy characterized by congenital muscle weakness, structural brain anomalies, and intellectual disabilities. The condition is part of a group of disorders known as dystroglycanopathies, which affect the dystroglycan protein complex—a key component in muscle cell stability and brain development.
The test, priced at 4400 AED, involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of genetic abnormalities in the POMT2 gene. This genetic testing is crucial for early diagnosis and management of the condition, allowing for targeted interventions and support to improve the quality of life for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, providing essential genetic insights for patients dealing with this challenging condition.
